Figure 3.
Figure 3. Analysis of binding of patients' IgG to factor XIa by Western blotting. Factor XIa was electrophoresed on 8% SDS-PAGE (0.2 μg per lane) under reducing conditions, followed by transfer to a PVDF membrane. Each lane was then incubated with the IgG of the patients (lanes 1-4), and one lane was incubated with goat antihuman factor XI IgG (control). The lanes were then processed as described in “Patients, materials, and methods.” The 50-kDa heavy chain (HC) and the 30-kDa light chain (LC) are depicted. Normal control IgG and IgG purified from a type II homozygote with no inhibitor failed to recognize factor XI (data not shown).

Analysis of binding of patients' IgG to factor XIa by Western blotting. Factor XIa was electrophoresed on 8% SDS-PAGE (0.2 μg per lane) under reducing conditions, followed by transfer to a PVDF membrane. Each lane was then incubated with the IgG of the patients (lanes 1-4), and one lane was incubated with goat antihuman factor XI IgG (control). The lanes were then processed as described in “Patients, materials, and methods.” The 50-kDa heavy chain (HC) and the 30-kDa light chain (LC) are depicted. Normal control IgG and IgG purified from a type II homozygote with no inhibitor failed to recognize factor XI (data not shown).

Close Modal

or Create an Account

Close Modal
Close Modal